About Sanogenetics
Sano Genetics is a Cambridge, UK-based precision medicine platform that combines genetic testing, participant recruitment, and long-term engagement to accelerate clinical trials. It serves pharmaceutical companies, biotechs, and academic researchers by enabling them to find, screen, and engage study participants faster and more cost-effectively. The platform supports research across common and rare diseases, integrating AI tools to streamline trial operations.
Open positions (1)
Company details
Funding
Total raised
$22M
Last stage
Series A
Investors
Founders
Patrick Short
Experienced in genomics research with a focus on large-scale genome sequencing projects and rare disorders. Previously at the Wellcome Trust Sanger Institute and the University of Cambridge.
LinkedIn
Charlotte Guzzo
Studied postgraduate genomics at the University of Cambridge, specialising in the embryonic origins of childhood cancer. Previously a risk analyst at JP Morgan.
LinkedIn
William Jones
Experienced in single-cell genomics research, studying childhood cancer. Previously at the Wellcome Trust Sanger Institute, the University of Cambridge and JPMorgan.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.